These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 32860704)

  • 1. Interleukin-17-induced neutrophil extracellular traps mediate resistance to checkpoint blockade in pancreatic cancer.
    Zhang Y; Chandra V; Riquelme Sanchez E; Dutta P; Quesada PR; Rakoski A; Zoltan M; Arora N; Baydogan S; Horne W; Burks J; Xu H; Hussain P; Wang H; Gupta S; Maitra A; Bailey JM; Moghaddam SJ; Banerjee S; Sahin I; Bhattacharya P; McAllister F
    J Exp Med; 2020 Dec; 217(12):. PubMed ID: 32860704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of tumor-associated neutrophils by lorlatinib attenuates pancreatic cancer growth and improves treatment with immune checkpoint blockade.
    Nielsen SR; Strøbech JE; Horton ER; Jackstadt R; Laitala A; Bravo MC; Maltese G; Jensen ARD; Reuten R; Rafaeva M; Karim SA; Hwang CI; Arnes L; Tuveson DA; Sansom OJ; Morton JP; Erler JT
    Nat Commun; 2021 Jun; 12(1):3414. PubMed ID: 34099731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reprogramming tumor immune microenvironment by milbemycin oxime results in pancreatic tumor growth suppression and enhanced anti-PD-1 efficacy.
    Gaikwad S; Srivastava SK
    Mol Ther; 2024 Sep; 32(9):3145-3162. PubMed ID: 39097773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCL2-mediated monocytes regulate immune checkpoint blockade resistance in pancreatic cancer.
    Li X; He G; Liu J; Yan M; Shen M; Xu L; An M; Huang J; Gao Z
    Int Immunopharmacol; 2022 May; 106():108598. PubMed ID: 35183036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A combined model of serum neutrophil extracellular traps, CD8
    Guo J; Shu T; Zhang H; Huang N; Ren J; Lin L; Wu J; Wang Y; Huang Z; Bin J; Liao Y; Shi M; Liao W; Huang N
    FEBS J; 2024 Aug; 291(15):3403-3416. PubMed ID: 38661680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic Epithelial IL17/IL17RA Signaling Drives B7-H4 Expression to Promote Tumorigenesis.
    Castro-Pando S; Howell RM; Li L; Mascaro M; Faraoni EY; Le Roux O; Romanin D; Tahan V; Riquelme E; Zhang Y; Kolls JK; Allison JP; Lozano G; Moghaddam SJ; McAllister F
    Cancer Immunol Res; 2024 Sep; 12(9):1170-1183. PubMed ID: 38842383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage-Derived Granulin Drives Resistance to Immune Checkpoint Inhibition in Metastatic Pancreatic Cancer.
    Quaranta V; Rainer C; Nielsen SR; Raymant ML; Ahmed MS; Engle DD; Taylor A; Murray T; Campbell F; Palmer DH; Tuveson DA; Mielgo A; Schmid MC
    Cancer Res; 2018 Aug; 78(15):4253-4269. PubMed ID: 29789416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer.
    Pan Y; Lu F; Fei Q; Yu X; Xiong P; Yu X; Dang Y; Hou Z; Lin W; Lin X; Zhang Z; Pan M; Huang H
    J Hematol Oncol; 2019 Nov; 12(1):124. PubMed ID: 31771616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TIMP1 Triggers Neutrophil Extracellular Trap Formation in Pancreatic Cancer.
    Schoeps B; Eckfeld C; Prokopchuk O; Böttcher J; Häußler D; Steiger K; Demir IE; Knolle P; Soehnlein O; Jenne DE; Hermann CD; Krüger A
    Cancer Res; 2021 Jul; 81(13):3568-3579. PubMed ID: 33941611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DDR1-induced neutrophil extracellular traps drive pancreatic cancer metastasis.
    Deng J; Kang Y; Cheng CC; Li X; Dai B; Katz MH; Men T; Kim MP; Koay EA; Huang H; Brekken RA; Fleming JB
    JCI Insight; 2021 Sep; 6(17):. PubMed ID: 34237033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role and functional mechanisms of IL‑17/IL‑17R signaling in pancreatic cancer (Review).
    Liu W; Wang X; Wu W
    Oncol Rep; 2024 Nov; 52(5):. PubMed ID: 39219271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intratumoral neutrophil extracellular traps are associated with unfavorable clinical outcomes and immunogenic context in pancreatic ductal adenocarcinoma.
    Chen X; Ma H; Mo S; Yu S; Lu Z; Chen J
    Front Immunol; 2022; 13():1027459. PubMed ID: 36325339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ablative Radiotherapy Reprograms the Tumor Microenvironment of a Pancreatic Tumor in Favoring the Immune Checkpoint Blockade Therapy.
    Lee YH; Yu CF; Yang YC; Hong JH; Chiang CS
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon gamma inhibits CXCL8-CXCR2 axis mediated tumor-associated macrophages tumor trafficking and enhances anti-PD1 efficacy in pancreatic cancer.
    Zhang M; Huang L; Ding G; Huang H; Cao G; Sun X; Lou N; Wei Q; Shen T; Xu X; Cao L; Yan Q
    J Immunother Cancer; 2020 Feb; 8(1):. PubMed ID: 32051287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond the concept of cold and hot tumors for the development of novel predictive biomarkers and the rational design of immunotherapy combination.
    De Guillebon E; Dardenne A; Saldmann A; Séguier S; Tran T; Paolini L; Lebbe C; Tartour E
    Int J Cancer; 2020 Sep; 147(6):1509-1518. PubMed ID: 31997345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-Cell RNA Sequencing Reveals Stromal Evolution into LRRC15
    Dominguez CX; Müller S; Keerthivasan S; Koeppen H; Hung J; Gierke S; Breart B; Foreman O; Bainbridge TW; Castiglioni A; Senbabaoglu Y; Modrusan Z; Liang Y; Junttila MR; Klijn C; Bourgon R; Turley SJ
    Cancer Discov; 2020 Feb; 10(2):232-253. PubMed ID: 31699795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CDK4/6 inhibition promotes immune infiltration in ovarian cancer and synergizes with PD-1 blockade in a B cell-dependent manner.
    Zhang QF; Li J; Jiang K; Wang R; Ge JL; Yang H; Liu SJ; Jia LT; Wang L; Chen BL
    Theranostics; 2020; 10(23):10619-10633. PubMed ID: 32929370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous injection of the oncolytic virus M1 awakens antitumor T cells and overcomes resistance to checkpoint blockade.
    Liu Y; Cai J; Liu W; Lin Y; Guo L; Liu X; Qin Z; Xu C; Zhang Y; Su X; Deng K; Yan G; Liang J
    Cell Death Dis; 2020 Dec; 11(12):1062. PubMed ID: 33311488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CDK1/2/5 inhibition overcomes IFNG-mediated adaptive immune resistance in pancreatic cancer.
    Huang J; Chen P; Liu K; Liu J; Zhou B; Wu R; Peng Q; Liu ZX; Li C; Kroemer G; Lotze M; Zeh H; Kang R; Tang D
    Gut; 2021 May; 70(5):890-899. PubMed ID: 32816920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stromal Modulation Reverses Primary Resistance to Immune Checkpoint Blockade in Pancreatic Cancer.
    Zhao J; Xiao Z; Li T; Chen H; Yuan Y; Wang YA; Hsiao CH; Chow DS; Overwijk WW; Li C
    ACS Nano; 2018 Oct; 12(10):9881-9893. PubMed ID: 30231203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.